GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
108 hedge funds and large institutions have $1.03B invested in GW Pharmaceuticals Plc American Depositary Shares in 2016 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 25 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 26
12% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 25
10% more capital invested
Capital invested by funds: $930M → $1.03B (+$96.1M)
3% more funds holding
Funds holding: 105 → 108 (+3)
29% less call options, than puts
Call options by funds: $53.7M | Put options by funds: $76M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$26.3M |
| 2 |
Millennium Management
New York
|
+$26.3M |
| 3 |
DM
Deerfield Management
New York
|
+$20M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$10.7M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$8.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$21.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.6M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$15.3M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$7.45M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$7.31M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Simplex Trading
Chicago,
Illinois
| – | -$59.9K | -1,092 | Closed |
|
|
SFPIA
127
Stevens First Principles Investment Advisors
Newport Beach,
California
| – | -$35K | -500 | Closed |
|
|
ACS
128
Archford Capital Strategies
Swansea,
Illinois
| – | -$22K | -304 | Closed |
|
|
AFP
129
Ausdal Financial Partners
Davenport,
Iowa
| – | -$13K | -193 | Closed |
|
|
FWM
130
Focused Wealth Management
Newburgh,
New York
| – | -$12K | -168 | Closed |
|
131
Bessemer Group
Woodbridge,
New Jersey
| – | -$11K | -165 | Closed |
|
|
SBL
132
Sargent Bickham Lagudis
Boulder,
Colorado
| – | +$55 | +1 | New |
|
GWPH Hedge Fund Activity: Q1 2016 in Review
108 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2016, worth a combined $1.03B — up 10% from $930M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new GWPH positions and 25 closed out — a net gain of 3 holders — while 31 added to existing stakes and 26 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $26.3M. The largest seller was VHCP Management, exiting entirely with an estimated $21.7M sold.
- 108 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2016, up from 105 in Q4 2015.
- Funds reported $1.03B of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2016, up 10% quarter-over-quarter.
- 28 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2016 and 25 closed out, a net change of +3 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2016 was Point72 Asset Management, an estimated $26.3M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2016 was VHCP Management, an estimated $21.7M sold.
Based on aggregated 13F filings for Q1 2016.